Description
What is Zepbound?
Zepbound (tirzepatide) is an FDA-approved medicine used for weight loss and weight management to help you lose weight and keep weight off . It is also used for obstructive sleep apnea (OSA) with obesity. It works by reducing your appetite and making you feel full more quickly and for a longer period of time, so you eat less and lose weight. Zepbound for weight loss and sleep apnea is given as a once-weekly injection under the skin and should be used together with diet and exercise.
When Zepbound was used for weight loss patients lost an average of 48 lbs, or 20.9% of their body weight . Compared to 7.1 lb, or 3.1%, for a placebo over 72 weeks in clinical (Study 1).
When it was used for obstructive sleep apnea 42% of adults had no sleep apnea or mild, non-symptomatic OSA after 1 year of treatment . Compared to 16% using placebo (SURMOUNT-OSA phase 3 clinical trials). Zepbound obstructive sleep apnea patients also had an average weight loss of 45 lbs (18% of their body weight).
Also , Zepbound is FDA-approved for chronic weight management in adults with:
- obesity (with a BMI of 30 kg/m2 or greater)
- overweight (with a BMI of 27 kg/m2 or greater) and also have weight-related medical problems . These include high blood pressure (hypertension), high cholesterol (dyslipidemia), type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease.
Zepbound is FDA-approved to treat:
- obstructive sleep apnea (OSA) that is moderate to severe in adults with obesity.
